C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/304, 260/279
C07D 498/10 (2006.01) C07D 209/38 (2006.01)
Patent
CA 1171860
Abstract A series of novel spiro-oxindole oxazolidinedione derivatives have been prepared, including their base salts with pharmacologically acceptable cations. These compounds are useful in therapy as aldose reductase inhibitors for the control of certain chronic diabetic complications. Preferred compounds include 1-(p-fluorophenyl)-5-fluoro-spiro-[indoline- 3,5'-oxazolidine]-2,2',4'-trione, 1-methyl-5-chloro- spiro-[indoline-3,5'-oxazolidine]-2,2',4'-trione, 1-isopropyl-5-chloro-spiro-[indoline-3,5'-oxazolidine]- 2,2',4'-trione and 1-(p-chlorobenzyl)-5-chloro-spiro- [indoline-3,5'-oxazolidine]-2,2',4'-trione. Methods for preparing these compounds from known starting materials are provided.
413239
Limited Pfizer
Smart & Biggar
LandOfFree
Oxazolidinedione derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazolidinedione derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolidinedione derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1300709